baber/WOPTO huggingface dataset:
Patent NZ-528303-A (NZ)
Title: Additive for dewaterable slurry
Inventor: NAJI BASIL
IPC: B05D7/24
Filed: 2002-03-04
Abstract: Disclosed is an additive for providing a water reduction effect in a cementitious slurry, wherein the additive comprises a plasticiser and one or both of the following mineral components: i) fly ash having a predominant particle size of up to 10 microns; ii) aluminous material having a predominant particle size of up to 150 microns, selected from the group consisting of hydrated alumina, partially hydrated alumina and unhydrated alumina. Also disclosed is a cementitious slurry containing the above additive.
Patent NZ-529629-A (NZ)
Title: Shale hydration inhibition agent and method of use
Inventor: PATEL ARVIND D
IPC: C09K8/20
Filed: 2002-06-13
Abstract: A water-base fluid for use in drilling wells and other drilling operation that includes a shale which swells in the presence of water is disclosed, wherein the fluid includes: an aqueous based continuous phase, a swellable shale material, and a shale hydration inhibition agent having the formula: H2N-R-{OR'}x-Y in which R and R' are alkylene groups having 1 to 6 carbon atoms and x is a value from 1 to 25; Y is an amine or alkoxy group, preferably a primary amine or a methoxy group; wherein the shale hydration inhibition agent should be present in sufficient concentration to reduce the swelling of the shale. The fluid may be used for formulating drilling fluids such as invert emulsion drilling muds or clear brine drilling fluids. The fluid may also be used in the slurrification and disposal of drill cuttings that contain water swellable clays or shales.
Patent NZ-530086-A (NZ)
Title: Pharmaceutical formulation
Inventor: GAIK-LIM KHOO CYNTHIA
IPC: A61K31/397
Filed: 2002-06-19
Abstract: An oral pharmaceutical formulation is described that contains iota-carrageenan, at least one neutral gelling polymers and a basic pharmaceutically active ingredient. This formulation inhibits the release of the basic pharmaceutically active ingredient from the formulation at acidic pH. Also mentioned is the manufacture and use of this formulation as a medicament for the treatment of a cardiovascular disorder.
Patent NZ-532881-A (NZ)
Title: Antibodies that immunospecifically bind to trail receptors
Inventor: SALCEDO THEODORA
IPC: C07K16/30
Filed: 2002-12-19
Abstract: Disclosed are antibodies and related molecules that immunospecifically bind to TRAIL receptor, TR7. Such antibodies have uses, for example, in the prevention and treatment of cancers and other proliferative disorders. Also disclosed are nucleic acid molecules encoding anti-TR7 antibodies, vectors and host cells containing these nucleic acids, and methods for producing the same. Furthermore methods and compositions for preventing, detecting, diagnosing, treating or ameliorating a disease or disorder, especially cancer and other hyperproliferative disorders, comprising administering to an animal, preferably a human, an effective amount of one or more antibodies or fragments or variants thereof, or related molecules, that immunospecifically bind to TRAIL receptor TR7 are disclosed.
Patent NZ-536267-A (NZ)
Title: Multi-phase, multi-compartment and multi-ingredient capsular system
Inventor: MILLER FRED H
IPC: A61K9/48
Filed: 2003-04-09
Abstract: Disclosed herein is a multi-compartment capsule, comprising, a first receiving chamber comprising at least one ingredient having a first physical state, wherein said ingredient is selected from the group consisting of a nutraceutical, a vitamin, a dietary supplement and a mineral; and a second receiving chamber comprising at least one ingredient having a second physical state, wherein said ingredient is selected from the group consisting of a nutraceutical, a vitamin, a dietary supplement and a mineral; wherein said first physical state of said ingredient of said first receiving chamber being different from said second physical state of said ingredient of said second receiving chamber; and said ingredient of said first receiving chamber being different from said ingredient of said second receiving chamber.
Patent NZ-537329-A (NZ)
Title: Resin-impregnated substrate, method of manufacture and system therefor
Inventor: COLVIN JOHN
IPC: B27N7/00
Filed: 2002-02-13
Abstract: An article comprising a pre-formed lignocellulosic substrate impregnated with a polyisocyanate material, wherein the impregnated lignocellulosic substrate comprises a smooth, low-gloss finish. The lignocellulosic substrate may comprise material selected from medium density fibreboard, high density fibreboard, oriented strand board, particle board, hemp, sisal, cotton stalk, wheat, straw, bamboo, jute, salt water reeds, palm fronds, flax, groundnut shells, hard woods and soft woods. (62) Divided out of 527376
Patent NZ-537377-A (NZ)
Title: Adjustable plastic carry strap having laterally projecting foldable handles
Inventor: AGAYOF JACOBV
Filed: 2003-10-24
Abstract: An adjustable carry strap and handle for facilitating the lifting of an object, such as a roll of material. The carry strap and handle has an elongated and substantially planar strap (110). Coupling portions (120,150) are provided on the strap to enable the carry strap and handle to attach to itself when looping around an object to be carried, to a second carry strap and handle, or to another device. A handle (140a,140b) is provided on the carry strap and handle to facilitate comfortable carrying by a user of the object to be carried. The handle is initially coplanar with the carry strap and handle but folds into a substantially upright position when in use for increased comfort and safety for the user.
Patent NZ-542039-A (NZ)
Title: Method for producing a pharmaceutical composition in the form of fibrate-containing tablets and tablets produced by same
Inventor: BESSE JEROME
IPC: A61K31/216
Filed: 2004-02-27
Abstract: Disclosed is a method for producing a pharmaceutical composition containing a fenofibrate active substance or one of the derivatives thereof, possibly associated to a second active substance, in the form of tablets. The method is characterised in that it consists of a stage for compacting said active substance and excipients by dry granulation.
Patent NZ-544347-A (NZ)
Title: Method and apparatus for raising and supporting a flag or banner or the like
Inventor: HUME PETER JOHN
Filed: 2005-12-22
Abstract: An object (1), is secured to a distal part of a flexible elongate member(4) that is inserted into a hollow interior (3) of an elongate tubular constraint (2). An intermediate length portion of the member is constrained within the constraint. A force applied to a proximal part of the member is directed longitudinally toward the distal part, and transferred as a compressive internal force along the intermediate portion to move it longitudinally within the hollow constraint and to move the object to a new location at which the object can be supported. A flexible and resilient member is pushed up a tube having a slot extending along the tube. A flag or similar object secured to the top end of the member extends out through the slot. An operator at ground level can push the member and attached flag into and up the tube to raise and fly the flag at an elevated position.
Patent NZ-547508-A (NZ)
Title: Use of vinpocetine to avoid complications in particular those associated with hearing which occur with epilepsy, and treatment thereof
Inventor: SITGES BERRONDO MARIA
IPC: A61K/
Filed: 2003-10-28
Abstract: Disclosed is the use of vinpocetine in the preparation of a medicament for inhibiting auditory tract alterations and hearing loss caused by epilepsy. The results obtained from experimental models of epilepsy in vivo showed that vinpocetine inhibits alterations of waves of the auditory brainstem response (ABR) which accompany the cortical epileptic activity during the ictal and post-ictal period.
Patent NZ-556605-A (NZ)
Title: Plants having increased yield and a method for making the same
Inventor: FRANKARD VALERIE
IPC: A01H5/00
Filed: 2006-01-27
Abstract: Provided is a method for increasing plant yield relative to corresponding wild type plants, comprising increasing the expression in a plant of a nucleic acid encoding a synovial sarcoma translocation (SYT) polypeptide or homologue thereof, , wherein said SYT polypeptide or homologue comprises from N-terminal to C-terminal: (i) an SNH domain having at least 40% sequence identity to the SNH domain of SEQ 10 NO: 2; and (ii) a Met-rich domain; and (iii) a QG-rich domain. Further provided are corresponding transgenic plants and plant products obtained using said plants.
Patent NZ-562991-A (NZ)
Title: Frozen dough thawer
Inventor: WILLETT PAUL EATON
IPC: A21B1/26
Filed: 2006-05-24
Abstract: A thawer comprises an enclosure 41, a plenum with a number of outlets for gas, one or more trays or conveyances 1 for supporting frozen dough pieces 1 and positioning them relative to the outlets such that the gas stream from the outlets will wash over them. The gas stream has a velocity sufficient to dry the surface of the frozen dough pieces 1.
Patent NZ-566617-A (NZ)
Title: Oligonucleotide analogues incorporating 5-aza-cytosine therein
Inventor: PHIASIVONGSA PASIT
IPC: C12N15/11
Filed: 2006-09-25
Abstract: A dinucleotide analogue which incorporates a 5-aza-cytosine as a base residue in the sequence of the dinucleotide analogue. The dinucleotide is linked with a phospholinker and has the general formula of: a. Z-L-G, or G-L-Z, wherein Z is 5-aza-cytosine; G is guanine and L is a phospholinker covalently linking Z and G; or b. 5'-DpG-3' or 5'GpD-3', wherein D is decitabine; p is a phospholinker; and G is deoxyguanosine. The dinucleotide can be used in a method for inhibiting DNA methylation or for treating diseases associated with aberrant DNA methylation.
Patent NZ-574121-A (NZ)
Title: Polyethylene glycol-conjugated gylcosylated neublastin and uses thereof for treatment of pain
Inventor: SAH DINAH WEN-YEE
IPC: C12N/
Filed: 2004-04-16
Abstract: Disclosed is a dimer composed of two neublastin polypeptides that are glycosylated and also conjugated through the N-terminus to a water-soluble synthetic polymer. The water-soluble synthetic polymer can be a polyalkylene glycol moiety, in particular, polyethylene glycol (PEG). The dimer can be used for the treatment of neuropathic pain, tactile allodynia or thermal hyperalgesia. (62) Divided Out of 543365
Patent NZ-575281-A (NZ)
Title: Pickering emulsion formulations
Inventor: FOWLER JEFFREY
IPC: C05G3/60
Filed: 2007-08-30
Abstract: Disclosed is a liquid pesticidal emulsion composition comprising (a) an aqueous continuous phase; (b) at least one colloidal solid; and (c) a dispersed oil emulsion phase comprising (i) at least one substantially water-insoluble pesticidally active ingredient, which is either itself an oily liquid comprising the oil phase, is a solid but is dissolved in an oily liquid present in the oil phase, is a solid and is dispersed within the oil phase or is present as a colloidal solid adsorbed to the liquid-liquid interface between the continuous aqueous phase and the dispersed oil phase; and (ii) at least one Ostwald ripening inhibitor soluble or miscible in the oil phase or which itself serves as the oil phase, and wherein if the composition further comprises an emulsifier formed of a low molecular weight or polymeric surfactant, the composition comprises less than 0.5 weight % of the emulsifier. Also disclosed is a method of combating pests in crops and a method for treating building materials or hides comprising applying the above emulsion to the crops or building material.
Patent NZ-575471-A (NZ)
Title: Vaccine comprising an oil in water emulsion adjuvant
Inventor: BALLOU WILLIAM RIPLEY
IPC: A61K39/39
Filed: 2007-10-10
Abstract: Disclosed is an immunogenic composition of an antigen and an adjuvant. The adjuvant consists of an oil in water emulsion, wherein said oil in water emulsion comprises 1 to 6 mg squalene, 1 to 7 mg tocol and 0.4 to 3 mg emulsifying agent, per human dose, wherein said human dose is between 0.25 and 1.5 mL. Also disclosed is the antigen being prepared from influenza virus.
Patent NZ-576170-A (NZ)
Title: A clay roof tile
Inventor: STACEY BLAKE EDWARD
IPC: E04D1/16
Filed: 2009-04-09
Abstract: A clay roof tile, the tile being generally square or rectangular and having a pair of side edges (11, 12), leading and trailing edges (13, 14) and front and rear surfaces (15, 16). A first of the pair of side edges (11) forms an underlap (20) and the second of the pair of side edges (12) forms an overlap (21) so that the underlap of one tile underlies the overlap of another tile when a pair of tiles are laid next to each other. The rear surface includes a drift bar (28) upstanding from the rear surface and extending widthwise of the tile in a direction between the side edges. The rear surface (16) includes a plurality of strengthening ribs (25, 27). The portion of the front surface (15) which is exposed in a tiled roof is substantially flat and the leading end (13) extends from the front surface and is generally curved in a direction so that the distal end of the leading end rests upon the front surface of an adjacent tile, at or adjacent the trailing edge (14) of the adjacent tile, when a pair of tiles are laid end to end.
Patent NZ-582010-A (NZ)
Title: Electrochemical dispenser
Inventor: MAGET HENRI J R
IPC: A01M1/20
Filed: 2008-06-12
Abstract: Disclosed is a device (60) for achieving a controlled low emanation rate of small volumes of liquid solutions (37), such as single or multi-component solutions, fragrances, or pheromones, for pest and insect management or fragrance enhancement, having a housing (61) with an upper chamber (97) to hold a bladder (62) containing liquid solution (37) to be released, a lower chamber (91) containing an electro-chemical gas generator (66), a collector pad (64) for receiving liquid solution (37) from the bladder (62), and a cap (65) which, when translated downward, activates a gas generator (66) which fills the upper chamber (97) with gas exerting pressure on the bladder (62), which in turn forces the liquid solution (37) from the bladder (62) onto the pad (64) for release to the environment.
Patent NZ-591290-A (NZ)
Title: Water purification using a vertical stack of boilers
Inventor: MILLAR FREDERICK WILLIAM
IPC: C02F1/04
Filed: 2010-02-23
Abstract: A water purification apparatus 10 comprises a plurality of boilers in a stack, the stack substantially defining a tower, the tower having a first end positionable above a mounting surface, and having a distal end opposite the first end. Each boiler in the stack has a heating chamber defined by a vertically disposed sidewall, a first endwall, and a second endwall situated overhead of the first endwall, a casing surrounding the sidewall and extending between the first endwall and the second endwall, a void substantially surrounding the sidewall between the casing and the sidewall, first apertures communicating between the heating chamber and the void and positioned adjacent to ,the second sidewall, secondary apertures communicating through the second endwall and providing communication between the respective voids surrounding the heating chambers of the boilers in the stack, a heating element positioned in the void adjacent to the sidewall of each of the boilers in the stack, and means to inject a mist of water into each the heating chamber. The heating element provides a first means to heat the heating chamber to a temperature adapted for the formation of steam from the mist. The formation of the steam provides means to separate dissolved solids from the water. Communication of the steam through the first apertures of the heating chamber to the void and the distal end of the tower provides secondary means to heat the respective sidewalls of the overhead boilers. Steam exiting the distal end of the tower is captured and cooled to form water.
Patent NZ-594497-A (NZ)
Title: A child resistant container comprising two hingedly connected lids, openable by disengaging a child resistant lock
Inventor: WALSH PHILIP
IPC: B65D25/10
Filed: 2010-02-04
Abstract: A child resistant container (10) with a container cavity (20), a primary lock means (50) and a secondary lock means (80). The container cavity is defined by a pair of lids (14, 16) which are hingedly connected to one another. The primary lock means includes a first lock assembly on one lid which engages with a second lock assembly on the other lid. A primary lock actuation includes an externally open topped pocket (60) formed in the body of one lid. The pocket has a pocket side wall (62) which is resiliently deflectable from a lock position to an unlock position. The pocket is shaped and sized to permit a finger of an operative to enter the pocket to effect deflection of the pocket side wall to its unlock position. The secondary lock means includes a third latch member (82) mounted on a resiliently deflectable tongue (84) which is externally located on a lid. A fixed co-operating fourth latch member (86) is fixedly mounted on the other lid for locking engagement with the third latch member. The secondary lock means is unlocked by deflecting the tongue inwards of the container. The secondary lock means is independent of the primary lock means and so both lock means need to be operated independently of each other in order to enable the lids to open.
Patent NZ-594659-A (NZ)
Title: Multiple layered lng tank
Inventor: EZZARHOUNI ADNAN
IPC: F17C3/02
Filed: 2010-03-11
Abstract: A liquefied natural gas tank, including a support structure (11) and a sealed and thermally insulated tank for containing liquefied natural gas, each wall of the tank having, in series in the direction of the thickness from the inside toward the outside of the tank, a primary sealed barrier, a primary thermally insulated barrier, a secondary sealed barrier and a secondary thermally insulated barrier. The secondary sealed barrier of a vertical wall includes a first sealed layer located at the top of the wall and a connection device sealingly connecting the first sealed layer to the support structure. The connection device includes a first metal plate (22) parallel to the first sealed layer, and a second sealed layer (17) which is adhered to the first sealed layer, as well as connected to the first metal plate.
Patent NZ-595727-A (NZ)
Title: Vitamin d receptor agonists and uses thereof
Inventor: KAWAI MEGUMI
IPC: A61K31/59
Filed: 2010-04-12
Abstract: 595727 Disclosed herein is a compound of Formula (I), in which R1, R2, R3, R4, R5, R6, X, and a are defined herein, or a pharmaceutically acceptable salt thereof. Also disclosed is a pharmaceutical composition comprising a compound or salt thereof of and a method of treating a disease which benefits from the modulation of the vitamin D receptor, such as a bone disorder, cardiovascular disease, a cardiovascular complication associated with renal disease, endothelial dysfunction, hyperparathyroidism, hypocalcemia, an immune disorder, left ventricular hypertrophy, a proliferative disease, proteinuria, renal disease, and thrombosis.
Patent NZ-596786-A (NZ)
Title: Electric fence wire separator
Inventor: MALINS CRAIG DAVID
IPC: E04H17/00
Filed: 2011-11-30
Abstract: The present invention relates to a conductive link and method of use in constructing a security system. The link includes a substantially flat elongate body aligned substantially within a first plane. At least one tab extends from each end of the body, each tab having an attachment portion configured to connect an end of the conductive link directly or indirectly to an electric fence strainer. The tabs and attachment portions are positioned substantially within a second plane oriented to be substantially non parallel to the first plane.
Patent NZ-601760-A (NZ)
Title: Compositions and methods for targeting type 1 interferon producing cells
Inventor: VAIRO GINO LUIGI
IPC: A61K39/395
Filed: 2011-02-17
Abstract: NZ 601760 Disclosed is the use of an immunoglobulin which binds an interleukin 3 receptor ? (IL-3R?) chain and competitively inhibits the binding of monoclonal antibody 7G3 to IL-3R? and which depletes or at least partly eliminates plasmacytoid dendritic cells (pDCs) and basophils to which it binds in the manufacture of a medicament for treating lupus in the mammal, wherein the immunoglobulin is not conjugated to a toxic compound that kills a cell to which the immunoglobulin binds, and wherein the immunoglobulin induces an enhanced level of enhanced effector function.
Patent NZ-601928-A (NZ)
Title: A radio beacon and method for selective radio communication between a radio beacon and first and second onboard units in accordance with 5.8 and 5.9 GHz DSRC standards
Inventor: SMELY DIETER
IPC: H04B1/38
Filed: 2012-08-20
Abstract: A radio beacon and a method for selective radio communication between a radio beacon and first and second onboard units is disclosed. The radio beacon includes a first transceiver for radio communication with a first onboard unit in accordance with a 5.8 GHz DSRC standard and a second transceiver for radio communication with a second onboard unit in accordance with a 5.9 GHz DSRC standard. The first transceiver transmits a sequence of first data packets in a first frequency band and the second transceiver transmits or receives a second data packet in a second frequency band. The radio beacon is configured to delay the transmission of a data packet of the sequence of first data packets by a time duration of the second data packet when the second data packet appears in the second frequency band.
Patent NZ-604135-A (NZ)
Title: Method for purifying a fused pyrrolocarbazole derivative
Inventor: ALLWEIN SHAWN P
IPC: C07D487/14
Filed: 2011-05-17
Abstract: Disclosed is a method of preparing an acid complex of formula (Ia) such as 11-isobutyl-2-methyl-8-(2-pyrimidinylamino)-2,5,6,11,12,13-hexahydro-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one diacetate salt, comprising the steps of: i) contacting 11-isobutyl-2-methyl-8-amino-2,5,6,11,12,13-hexahydro-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one with a 2-halo-pyrimidine such as 2-bromopyrimidine in the presence of a base that is of formula R1R2R3N (such as triethylamine), and a solvent (such as n-butanol); ii) contacting the resulting compound of formula (I) with an acid RCOOH; and optionally iii) recovering the resulting acid complex of formula (Ia), wherein R is alkyl; R1 is alkyl; and R2 and R3 are independently H or alkyl. Further disclosed is a method of making and purifying 11-isobutyl-2-methyl-8-(2-pyrimidinylamino)-2,5,6,11,12,13-hexahydro-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one free base comprising preparing the an acid complex of formula (Ia) as defined above. Also disclosed is a crystalline acid complex of formula (Ia) which is the diacetic acid salt of 11-isobutyl-2-methyl-8-(2-pyrimidinylamino)-2,5,6,11,12,13-hexahydro-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one characterized by an X-ray powder diffractogram comprising one or more of the following peaks: 5.19 ± 0.2 degrees 2-Theta; 6.17 ± 0.2 degrees 2-Theta; 6.44 ± 0.2 degrees 2-Theta; 14.36 ± 0.2 degrees 2-Theta; and 26.09 ± 0.2 degrees 2-Theta, when measured using Cu-K radiation.
Patent NZ-608762-A (NZ)
Title: Forehead supports for facial masks
Inventor: HOWARD SCOTT ALEXANDER
IPC: G01B5/14
Filed: 2007-06-15
Abstract: 608762 Disclosed is a forehead support for a breathing or CPAP mask assembly to allow a better fit of the mask to the user. The forehead support comprises a frame connector provided to a mask frame and a forehead cushion support plate having a tube. The forehead cushion support plate is linearly adjustable with respect to the frame connector along a longitudinal axis of the tube between retracted and extended positions. At least two protrusions and at least two corresponding keyways are adapted to prevent rotation of the forehead cushion support plate about the longitudinal axis of the tube with respect to the frame connector. An actuator is disposed on the frame connector configured to adjustably secure the forehead cushion support plate to the frame connector. Spaced position markings are provided on the tube, and at least one of the position markings is numbered and at least one of the position markings is unnumbered.